Natural compounds as modulators of NADPH oxidases

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2013, Pages

  Maraldi, Tullia ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; BIOLOGICAL PRODUCT; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANIMAL; CELLS; DISEASES; DRUG EFFECT; HUMAN; METABOLISM; PATHOLOGY; REVIEW;

ANIMALS; ANTIOXIDANTS; BIOLOGICAL PRODUCTS; CELLS; DISEASE; HUMANS; NADPH OXIDASE; REACTIVE OXYGEN SPECIES;

EID: 84893826824     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2013/271602     Document Type: Review

References (96)

1. Schramm A., Matusik P., Osmenda G., Guzik T. J., Targeting NADPH oxidases in vascular pharmacology. Vascular Pharmacology 2012 56 5-6 216 231 2-s2.0-84858964091 10.1016/j.vph.2012.02.012
2. Coso S., Harrison I., Harrison C. B., Vinh A., Sobey C. G., Drummond G. R., Williams E. D., Selemidis S., NADPH oxidases as regulators of tumor angiogenesis: current and emerging concepts. Antioxidants and Redox Signaling 2012 16 11 1229 1247 2-s2.0-84859853336 10.1089/ars.2011.4489
3. Guzik T. J., Harrison D. G., Vascular NADPH oxidases as drug targets for novel antioxidant strategies. Drug Discovery Today 2006 11 11-12 524 533 2-s2.0-33646525680 10.1016/j.drudis.2006.04.003
4. Gao L., Mann G. E., Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling. Cardiovascular Research 2009 82 1 9 20 2-s2.0-62349116866 10.1093/cvr/cvp031
5. Keyer K., Gort A. S., Imlay J. A., Superoxide and the production of oxidative DNA damage. Journal of Bacteriology 1995 177 23 6782 6790 2-s2.0-0028871420
6. Rister M., Baehner R. L., The alteration of superoxide dismutase, catalase, glutathione peroxidase, and NAD(P)H cytochrome C reductase in guinea pig polymorphonuclear leukocytes and alveolar macrophages during hyperoxia. Journal of Clinical Investigation 1976 58 5 1174 1184 2-s2.0-0017149747
7. Nishikawa T., Edelstein D., Du X. L., Yamagishi S.-I., Matsumura T., Kaneda Y., Yorek M. A., Beebe D., Oates P. J., Hammes H.-P., Glardino I., Brownlee M., Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000 404 6779 787 790 2-s2.0-0034643340 10.1038/35008121 (Pubitemid 30212409)
8. Rhee S. G., Bae Y. S., Lee S. R., Kwon J., Hydrogen peroxide: a key messenger that modulates protein phosphorylation through cysteine oxidation. Science's STKE 2000 2000 53, article Pe1 2-s2.0-0034633602
9. Hofer T., Badouard C., Bajak E., Ravanat J.-L., Mattsson Å., Cotgreave I. A., Hydrogen peroxide causes greater oxidation in cellular RNA than in DNA. Biological Chemistry 2005 386 4 333 337 2-s2.0-25144486774 10.1515/BC.2005.040 (Pubitemid 41460233)
10. Spencer J. P., Jenner A., Chimel K., Aruoma O. I., Cross C. E., Wu R., Halliwell B., DNA strand breakage and base modification induced by hydrogen peroxide treatment of human respiratory tract epithelial cells. FEBS Letters 1995 374 2 233 236 2-s2.0-0028786295 10.1016/0014-5793(95)01117-W
11. Welles Kellogg E., Fridovich I., Superoxide, hydrogen peroxide, and singlet oxygen in lipid peroxidation by a xanthine oxidase system. The Journal of Biological Chemistry 1975 250 22 8812 8817 2-s2.0-0016719209
12. Stocker R., Keaney J. F. Jr., Role of oxidative modifications in atherosclerosis. Physiological Reviews 2004 84 4 1381 1478 2-s2.0-4644310560 10.1152/physrev.00047.2003 (Pubitemid 39302636)
13. Fraszczak J., Trad M., Janikashvili N., Cathelin D., Lakomy D., Granci V., Morizot A., Audia S., Micheau O., Lagrost L., Katsanis E., Solary E., Larmonier N., Bonnotte B., Peroxynitrite-dependent killing of cancer cells and presentation of released tumor antigens by activated dendritic cells. Journal of Immunology 2010 184 4 1876 1884 2-s2.0-77949896128 10.4049/jimmunol.0900831
14. Kooy N. W., Royall J. A., Ye Y. Z., Kelly D. R., Beckman J. S., Evidence for in vivo peroxynitrite production in human acute lung injury. American Journal of Respiratory and Critical Care Medicine 1995 151 4 1250 1254 2-s2.0-0028969011
15. Turan N. N., Yildiz G., Gumusel B., Demiryurek A. T., Ischemic and peroxynitrite preconditioning effects in chronic hypoxic rat lung. Experimental Lung Research 2008 34 6 325 341 2-s2.0-46749092519 10.1080/01902140802093212 (Pubitemid 351948462)
16. Cui X., Reactive oxygen species: the achilles' heel of Cancer cells? Antioxidants and Redox Signaling 2012 16 11 1212 1214 2-s2.0-84859833047 10.1089/ars.2012.4532
17. Mythri R. B., Venkateshappa C., Harish G., Mahadevan A., Muthane U. B., Yasha T. C., Srinivas Bharath M. M., Shankar S. K., Evaluation of Markers of oxidative stress, antioxidant function and astrocytic proliferation in the striatum and frontal cortex of Parkinson's disease brains. Neurochemical Research 2011 36 8 1452 1463 2-s2.0-79961207643 10.1007/s11064-011-0471-9
18. Shaerzadeh F., Alamdary S. Z., Esmaeili M. A., Sarvestani N. N., Khodagholi F., Neuroprotective effect of Salvia sahendica is mediated by restoration of mitochondrial function and inhibition of endoplasmic reticulum Stress. Neurochemical Research 2011 36 12 2216 2226 2-s2.0-80755139521 10.1007/s11064-011-0545-8
19. Powell S. B., Sejnowski T. J., Behrens M. M., Behavioral and neurochemical consequences of cortical oxidative stress on parvalbumin- interneuron maturation in rodent models of schizophrenia. Neuropharmacology 2012 62 3 1322 1331 2-s2.0-84856104234 10.1016/j.neuropharm.2011.01.049
20. Steckert A. V., Valvassori S. S., Moretti M., Dal-Pizzol F., Quevedo J., Role of oxidative stress in the pathophysiology of bipolar disorder. Neurochemical Research 2010 35 9 1295 1301 2-s2.0-77957843110 10.1007/s11064-010-0195-2
21. Guzik T. J., Griendling K. K., NADPH oxidases: molecular understanding finally reaching the clinical level? Antioxidants and Redox Signaling 2009 11 10 2365 2370 2-s2.0-70349322788 10.1089/ars.2009.2615
22. Bedard K., Krause K. H., The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiological Reviews 2007 87 1 245 313 2-s2.0-33846794822 10.1152/physrev.00044.2005 (Pubitemid 46209993)
23. Brown D. I., Griendling K. K., Nox proteins in signal transduction. Free Radical Biology and Medicine 2009 47 9 1239 1253 2-s2.0-70349804297 10.1016/j.freeradbiomed.2009.07.023
24. Takac I., Schröder K., Zhang L., Lardy B., Anilkumar N., Lambeth J. D., Shah A. M., Morel F., Brandes R. P., The E-loop is involved in hydrogen peroxide formation by the NADPH oxidase Nox4. The Journal of Biological Chemistry 2011 286 15 13304 13313 2-s2.0-79953881843 10.1074/jbc.M110.192138
25. Opitz N., Drummond G. R., Selemidis S., Meurer S., Schmidt H. H. H. W., The 'A's and 'O's of NADPH oxidase regulation: s commentary on 'Subcellular localization and function of alternatively spliced Noxo1 isoforms'. Free Radical Biology and Medicine 2007 42 2 175 179 2-s2.0-33845620993 10.1016/j. freeradbiomed.2006.11.003 (Pubitemid 44959749)
26. Lyle A. N., Deshpande N. N., Taniyama Y., Seidel-Rogol B., Pounkova L., Du P., Papaharalambus C., Lassègue B., Griendling K. K., Poldip2, a novel regulator of Nox4 and cytoskeletal integrity in vascular smooth muscle cells. Circulation Research 2009 105 3 249 259 2-s2.0-69249246990 10.1161/CIRCRESAHA. 109.193722
27. Diaz B., Shani G., Pass I., Anderson D., Quintavalle M., Courtneidge S. A., Tks5-dependent, nox-mediated generation of reactive oxygen species is necessary for invadopodia formation. Science Signaling 2009 2 88 ra53 2-s2.0-73949101383 10.1126/scisignal.2000368
28. Janiszewski M., Lopes L. R., Carmo A. O., Pedro M. A., Brandes R. P., Santos C. X. C., Laurindo F. R. M., Regulation of NAD(P)H oxidase by associated protein disulfide isomerase in vascular smooth muscle cells. The Journal of Biological Chemistry 2005 280 49 40813 40819 2-s2.0-28844477782 10.1074/jbc.M509255200 (Pubitemid 41780573)
29. Takeya R., Ueno N., Kami K., Taura M., Kohjima M., Izaki T., Nunoi H., Sumimoto H., Novel human hmologues of p47phox and p67phox participate in activation of superoxide-producing NADPH oxidases. The Journal of Biological Chemistry 2003 278 27 25234 25246 2-s2.0-0042991381 10.1074/jbc.M212856200 (Pubitemid 37548688)
30. Sumimoto H., Structure, regulation and evolution of Nox-family NADPH oxidases that produce reactive oxygen species. FEBS Journal 2008 275 15 3984 2-s2.0-47249126892 10.1111/j.1742-4658.2008.06546.x (Pubitemid 351990960)
31. Tirone F., Cox J. A., NADPH oxidase 5 (NOX5) interacts with and is regulated by calmodulin. FEBS Letters 2007 581 6 1202 1208 2-s2.0-33847731516 10.1016/j.febslet.2007.02.047 (Pubitemid 46385949)
32. Doughan A. K., Harrison D. G., Dikalov S. I., Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circulation Research 2008 102 4 488 496 2-s2.0-41949104144 10.1161/CIRCRESAHA.107.162800 (Pubitemid 351651106)
33. Chan E. C., Jiang F., Peshavariya H. M., Dusting G. J., Regulation of cell proliferation by NADPH oxidase-mediated signaling: potential roles in tissue repair, regenerative medicine and tissue engineering. Pharmacology and Therapeutics 2009 122 2 97 108 2-s2.0-64249117887 10.1016/j.pharmthera.2009.02. 005
34. Jiang F., Zhang Y., Dusting G. J., NADPH oxidase-mediated redox signaling: roles in cellular stress response, stress tolerance, and tissue repair. Pharmacological Reviews 2011 63 1 218 242 2-s2.0-79952026736 10.1124/pr.110.002980
35. Altenhöfer S., Kleikers P. W., Radermacher K. A., Scheurer P., Rob Hermans J. J., Schiffers P., Ho H., Wingler K., Schmidt H. H., The NOX toolbox: validating the role of NADPH oxidases in physiology and disease. Cellular and Molecular Life Sciences 2012 69 14 2327 2343
36. Prata C., Maraldi T., Fiorentini D., Zambonin L., Hakim G., Landi L., Nox-generated ROS modulate glucose uptake in a leukaemic cell line. Free Radical Research 2008 42 5 405 414 2-s2.0-46649100691 10.1080/10715760802047344 (Pubitemid 351935154)
37. Maraldi T., Prata C., Vieceli Dalla Sega F., Caliceti C., Zambonin L., Fiorentini D., Hakim G., NAD(P)H oxidase isoform Nox2 plays a prosurvival role in human leukaemia cells. Free Radical Research 2009 43 11 1111 1121 2-s2.0-70350534699 10.1080/10715760903186132
38. Komatsu D., Kato M., Nakayama J., Miyagawa S., Kamata T., NADPH oxidase 1 plays a critical mediating role in oncogenic Ras-induced vascular endothelial growth factor expression. Oncogene 2008 27 34 4724 4732 2-s2.0-49149110899 10.1038/onc.2008.102
39. Sareila O., Kelkka T., Pizzolla A., Hultqvist M., Holmdahl R., NOX2 complex-derived ROS as immune regulators. Antioxidants and Redox Signaling 2011 15 8 2197 2208 2-s2.0-79251644679 10.1089/ars.2010.3635
40. Halliwell B., Free radicals and antioxidants: updating a personal view. Nutrition Reviews 2012 70 5 257 265 2-s2.0-84860331697 10.1111/j.1753-4887.2012. 00476.x
41. Lam G. Y., Huang J., Brumell J. H., The many roles of NOX2 NADPH oxidase-derived ROS in immunity. Seminars in immunopathology 2010 32 4 415 430 2-s2.0-79953138339
42. Babior B. M., NADPH oxidase: an update. Blood 1999 93 5 1464 1476 2-s2.0-0033105874 (Pubitemid 29102471)
43. Williams M., Shatynski K., Chen H., The phagocyte NADPH oxidase (NOX2) regulates adaptive immune response at the level of both T cells and APSs. Journal of Immunology 2010 184 138, article 137
44. Gujral J. S., Hinson J. A., Farhood A., Jaeschke H., NADPH oxidase-derived oxidant stress is critical for neutrophil cytotoxicity during endotoxemia. American Journal of Physiology: Gastrointestinal and Liver Physiology 2004 287 1 G243 G252 2-s2.0-3042634915 10.1152/ajpgi.00287.2003 (Pubitemid 38802139)
45. Fazal N., Shamim M., Khan S. S., Gamelli R. L., Sayeed M. M., Neutrophil depletion in rats reduces burn-injury induced intestinal bacterial translocation. Critical Care Medicine 2000 28 5 1550 1555 2-s2.0-0034127153 (Pubitemid 30324538)
46. Wang Q., Tompkins K. D., Simonyi A., Korthuis R. J., Sun A. Y., Sun G. Y., Apocynin protects against global cerebral ischemia-reperfusion-induced oxidative stress and injury in the gerbil hippocampus. Brain Research 2006 1090 1 182 189 2-s2.0-33744509306 10.1016/j.brainres.2006.03.060 (Pubitemid 43817927)
47. Walder C. E., Green S. P., Darbonne W. C., Mathias J., Rae J., Dinauer M. C., Curnutte J. T., Thomas G. R., Ischemic stroke injury is reduced in mice lacking a functional NADPH oxidase. Stroke 1997 28 11 2252 2258 2-s2.0-0030663253 (Pubitemid 27497931)
48. Kusaka I., Kusaka G., Zhou C., Ishikawa M., Nanda A., Granger D. N., Zhang J. H., Tang J., Role of AT1 receptors and NAD(P)H oxidase in diabetes-aggravated ischemic brain injury. American Journal of Physiology: Heart and Circulatory Physiology 2004 286 6 H2442 H2451 2-s2.0-2542505446 10.1152/ajpheart.01169.2003 (Pubitemid 38685263)
49. Choi S. H., Lee Y., Kim S. U., Jin B. K., Thrombin-induced oxidative stress contributes to the death of hippocampal neurons in vivo: role of microglial NADPH oxidase. The Journal of Neuroscience 2005 25 16 4082 4090 2-s2.0-17644366783 10.1523/JNEUROSCI.4306-04.2005 (Pubitemid 40563383)
50. Zekry D., Kay Epperson T., Krause K.-H., A role for NOX NADPH oxidases in Alzheimer's disease and other types of dementia? IUBMB Life 2003 55 6 307 313 2-s2.0-0042027784 10.1080/1521654031000153049 (Pubitemid 36975540)
51. Qin B., Cartier L., Dubois-Dauphin M., Li B., Serrander L., Krause K.-H., A key role for the microglial NADPH oxidase in APP-dependent killing of neurons. Neurobiology of Aging 2006 27 11 1577 1587 2-s2.0-33748454440 10.1016/j.neurobiolaging.2005.09.036 (Pubitemid 44349157)
52. Gann P. H., Ma J., Giovannucci E., Willett W., Sacks F. M., Hennekens C. H., Stampfer M. J., Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Research 1999 59 6 1225 1230 2-s2.0-0033559952 (Pubitemid 29136251)
53. Gao H. M., Liu B., Hong J. S., Critical role for microglial NADPH oxidase in rotenone-induced degeneration of dopaminergic neurons. The Journal of Neuroscience 2003 23 15 6181 6187 2-s2.0-0038044029 (Pubitemid 36875618)
54. Cartier L., Hartley O., Dubois-Dauphin M., Krause K.-H., Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases. Brain Research Reviews 2005 48 1 16 42 2-s2.0-13444278829 10.1016/j.brainresrev.2004.07.021 (Pubitemid 40215781)
55. Vilhardt F., Plastre O., Sawada M., Suzuki K., Wiznerowicz M., Kiyokawa E., Trono D., Krause K.-H., The HIV-1 Nef protein and phagocyte NADPH oxidase activation. The Journal of Biological Chemistry 2002 277 44 42136 42143 2-s2.0-0036829915 10.1074/jbc.M200862200 (Pubitemid 35257530)
56. van der Goes A., Brouwer J., Hoekstra K., Roos D., van den Berg T. K., Dijkstra C. D., Reactive oxygen species are required for the phagocytosis of myelin by macrophages. Journal of Neuroimmunology 1998 92 1-2 67 75 2-s2.0-0032414199 10.1016/S0165-5728(98)00175-1 (Pubitemid 29015991)
57. Li J., Baud O., Vartanian T., Volpe J. J., Rosenberg P. A., Peroxynitrite generated by inducible nitric oxide synthase and NADPH oxidase mediates microglial toxicity to oligodendrocytes. Proceedings of the National Academy of Sciences of the United States of America 2005 102 28 9936 9941 2-s2.0-22244470745 10.1073/pnas.0502552102 (Pubitemid 40993671)
58. Halliwell B., The role of oxygen radicals in human disease, with particular reference to the vascular system. Haemostasis 1993 23 supplement 1 118 126 2-s2.0-0027465289 (Pubitemid 23116285)
59. Wingler K., Hermans J. J. R., Schiffers P., Moens A. L., Paul M., Schmidt H. H. H. W., NOX 1, 2, 4, 5: counting out oxidative stress. British Journal of Pharmacology 2011 164 3 866 883 2-s2.0-79957890774 10.1111/j.1476-5381.2011. 01249.x
60. Aldieri E., Riganti C., Polimeni M., Gazzano E., Lussiana C., Campia I., Ghigo D., Classical inhibitors of NOX NAD(P)H oxidases are not specific. Current Drug Metabolism 2008 9 8 686 696 2-s2.0-58149347478 10.2174/138920008786049285
61. O'Donnell V. B., Tew D. G., Jones O. T. G., England P. J., Studies on the inhibitory mechanism of iodonium compounds with special reference to neutrophil NADPH oxidase. Biochemical Journal 1993 290 1 41 49 2-s2.0-0027479814 (Pubitemid 23081198)
62. Wind S., Beuerlein K., Eucker T., Müller H., Scheurer P., Armitage M. E., Ho H., Schmidt H. H. H. W., Wingler K., Comparative pharmacology of chemically distinct NADPH oxidase inhibitors. British Journal of Pharmacology 2010 161 4 885 898 2-s2.0-77956813371 10.1111/j.1476-5381.2010.00920.x
63. 2+ pump. British Journal of Pharmacology 2009 158 3 790 796 2-s2.0-70350053122 10.1111/j.1476-5381.2009.00394.x
64. Diatchuk V., Lotan O., Koshkin V., Wikstroem P., Pick E., Inhibition of NADPH oxidase activation by 4-(2-aminoethyl)- benzenesulfonyl fluoride and related compounds. The Journal of Biological Chemistry 1997 272 20 13292 13301 2-s2.0-0030915096 10.1074/jbc.272.20.13292 (Pubitemid 27216760)
65. Stolk J., Hiltermann T. J., Dijkman J. H., Verhoeven A. J., Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol. American Journal of Respiratory Cell and Molecular Biology 1994 11 1 95 102 2-s2.0-0028473441
66. Ghosh M., Di Wang H., McNeill J. R., Role of oxidative stress and nitric oxide in regulation of spontaneous tone in aorta of DOCA-salt hypertensive rats. British Journal of Pharmacology 2004 141 4 562 573 2-s2.0-1842506278 10.1038/sj.bjp.0705557 (Pubitemid 38453248)
67. Engels F., Renirie B. F., 'T Hart B. A., Labadie R. P., Nijkamp F. P., Effects of apocynin, a drug isolated from the roots of Picrorhiza kurroa, on arachidonic acid metabolism. FEBS Letters 1992 305 3 254 256 2-s2.0-0026742529 10.1016/0014-5793(92)80680-F
68. Lapperre T. S., Jimenez L. A., Antonicelli F., Drost E. M., Hiemstra P. S., Stolk J., MacNee W., Rahman I., Apocynin increases glutathione synthesis and activates AP-1 in alveolar epithelial cells. FEBS Letters 1999 443 2 235 239 2-s2.0-0033023141 10.1016/S0014-5793(98)01723-2 (Pubitemid 29078639)
69. Heumüller S., Wind S., Barbosa-Sicard E., Schmidt H. H. H. W., Busse R., Schröder K., Brandes R. P., Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. Hypertension 2008 51 2 211 217 2-s2.0-38549138327 10.1161/HYPERTENSIONAHA.107.100214 (Pubitemid 351159930)
70. Münzel T., Gori T., Bruno R. M., Taddei S., Is oxidative stress a therapeutic target in cardiovascular disease? European Heart Journal 2010 31 22 2741 2749 2-s2.0-78649357316 10.1093/eurheartj/ehq396
71. Al-Awwadi N. A., Araiz C., Bornet A., Delbosc S., Cristol J.-P., Linck N., Azay J., Teissedre P.-L., Cros G., Extracts enriched in different polyphenolic families normalize increased cardiac NADPH oxidase expression while having differential effects on insulin resistance, hypertension, and cardiac hypertrophy in high-fructose-fed rats. Journal of Agricultural and Food Chemistry 2005 53 1 151 157 2-s2.0-11244292338 10.1021/jf048919f (Pubitemid 40066483)
72. Ryszawa N., Kawczyńska-Drózdz A., Pryjma J., Czesnikiewicz-Guzik M., Adamek-Guzik T., Naruszewicz M., Korbut R., Guzik T. J., Effects of novel plant antioxidants on platelet superoxide production and aggregation in atherosclerosis. Journal of Physiology and Pharmacology 2006 57 4 611 626 2-s2.0-33846256192 (Pubitemid 46096109)
73. Sarna L. K., Wu N., Hwang S.-Y., Siow Y. L., Karmin O., Berberine inhibits NADPH oxidase mediated superoxide anion production in macrophages. Canadian Journal of Physiology and Pharmacology 2010 88 3 369 378 2-s2.0-77950900334 10.1139/Y09-136
74. Heo S. K., Yun H. J., Noh E. K., Park S. D., Emodin and rhein inhibit LIGHT-induced monocytes migration by blocking of ROS production. Vascular Pharmacology 2010 53 1-2 28 37 2-s2.0-77952426455 10.1016/j.vph.2010.03.002
75. Noh J. S., Kim H. J., Kwon M. J., Song Y. O., Active principle of kimchi, 3-(4′-hydroxyl-3′5′- dimethoxyphenyl)propionic acid, retards fatty streak formation at aortic sinus of apolipoprotein e knockout mice. Journal of Medicinal Food 2009 12 6 1206 1212 2-s2.0-74349096666 10.1089/jmf.2009.0034
76. Takai S., Jin D., Kawashima H., Kimura M., Shiraishi-Tateishi A., Tanaka T., Kakutani S., Tanaka K., Kiso Y., Miyazaki M., Anti-atherosclerotic effects of dihomo- γ -linolenic acid in ApoE-deficient mice. Journal of Atherosclerosis and Thrombosis 2009 16 4 480 489 2-s2.0-73249117613
77. Pagonis C., Tauber A. I., Pavlotsky N., Simons E. R., Flavonoid impairment of neutrophil response. Biochemical Pharmacology 1986 35 2 237 245 2-s2.0-0022531277 (Pubitemid 16083502)
78. Pincemail J., Thirion A., Dupuis M., Ginkgo biloba extracts inhibits oxygen species production generated by phorbol myristate acetate stimulated human leukocytes. Experientia 1987 43 2 181 184 2-s2.0-0023164740 (Pubitemid 17020024)
79. Lin F. Y., Chen Y. H., Chen Y. L., Wu T. C., Li C. Y., Chen J. W., Lin S. J., Ginkgo biloba extract inhibits endotoxin-induced human aortic smooth muscle cell proliferation via suppression of toll-like receptor 4 expression and NADPH oxidase activation. Journal of Agricultural and Food Chemistry 2007 55 5 1977 1984 2-s2.0-33947573777 10.1021/jf062945r (Pubitemid 46479609)
80. Ciz M., Denev P., Kratchanova M., Vasicek O., Ambrozova G., Lojek A., Flavonoids inhibit the respiratory burst of neutrophils in mammals. Oxidative Medicine and Cellular Longevity 2012 2012 6 181295 10.1155/2012/181295
81. Chuang D. Y., Chan M. H., Zong Y., Sheng W., He Y., Jiang J. H., Simonyi A., Gu Z., Fritsche K. L., Cui J., Lee J. C., Folk W. R., Lubahn D. B., Sun A. Y., Sun G. Y., Magnolia polyphenols attenuate oxidative and inflammatory responses in neurons and microglial cells. Journal of Neuroinflammation 2013 10, article 15
82. Gustafson S. J., Dunlap K. L., McGill C. M., Kuhn T. B., A nonpolar blueberry fraction blunts NADPH oxidase activation in neuronal cells exposed to tumor necrosis factor- α Oxidative Medicine and Cellular Longevity 2012 2012 12 2-s2.0-84859747274 10.1155/2012/768101 768101
83. Nakashima T., Iwashita T., Fujita T., Sato E., Niwano Y., Kohno M., Kuwahara S., Harada N., Takeshita S., Oda T., A prodigiosin analogue inactivates NADPH oxidase in macrophage cells by inhibiting assembly of p47phox and Rac. Journal of Biochemistry 2008 143 1 107 115 2-s2.0-38849207515 10.1093/jb/mvm196 (Pubitemid 351197716)
84. Chang C. C., Wang Y. H., Chern C.-M., Liou K. T., Hou Y. C., Peng Y. T., Shen Y. C., Prodigiosin inhibits gp91phox and iNOS expression to protect mice against the oxidative/nitrosative brain injury induced by hypoxia-ischemia. Toxicology and Applied Pharmacology 2011 257 1 137 147 2-s2.0-81255134021 10.1016/j.taap.2011.08.027
85. Qian L., Xu Z., Zhang W., Wilson B., Hong J.-S., Flood P. M., Sinomenine, a natural dextrorotatory morphinan analog, is anti-inflammatory and neuroprotective through inhibition of microglial NADPH oxidase. Journal of Neuroinflammation 2007 4, article 23 2-s2.0-35948938955 10.1186/1742-2094-4-23 (Pubitemid 350066535)
86. Gundimeda U., McNeill T. H., Elhiani A. A., Schiffman J. E., Hinton D. R., Gopalakrishna R., Green tea polyphenols precondition against cell death induced by oxygen-glucose deprivation via stimulation of laminin receptor, generation of reactive oxygen species, and activation of protein kinase C ε The Journal of Biological Chemistry 2012 287 41 34694 34708
87. Ahn H. Y., Kim C. H., Ha T. S., Epigallocatechin-3-gallate regulates NADPH oxidase expression in human umbilical vein endothelial cells. Korean Journal of Physiology and Pharmacology 2010 14 5 325 329 2-s2.0-78649378897 10.4196/kjpp.2010.14.5.325
88. Chen F., Qian L. H., Deng B., Liu Z. M., Zhao Y., Le Y. Y., Resveratrol protects vascular endothelial cells from high glucose-induced apoptosis through inhibition of nadph oxidase activation-driven oxidative stress. CNS Neuroscience & Therapeutics 2013 19 9 675 681 10.1111/cns.12131
89. Tang Y., Xu J., Qu W., Peng X., Xin P., Yang X., Ying C., Sun X., Hao L., Resveratrol reduces vascular cell senescence through attenuation of oxidative stress by SIRT1/NADPH oxidase-dependent mechanisms. Journal of Nutritional Biochemistry 2012 23 11 1410 1416 2-s2.0-84856074699 10.1016/j.jnutbio.2011.08. 008
90. Drummond G. R., Selemidis S., Griendling K. K., Sobey C. G., Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nature Reviews Drug Discovery 2011 10 6 453 471 2-s2.0-79957890939 10.1038/nrd3403
91. Ding Y., Chen Z. J., Liu S., Che D., Vetter M., Chang C. H., Inhibition of Nox-4 activity by plumbagin, a plant-derived bioactive naphthoquinone. Journal of Pharmacy and Pharmacology 2005 57 1 111 116 2-s2.0-11144322792 10.1211/0022357055119 (Pubitemid 40030109)
92. Tian L., Yin D., Ren Y., Gong C., Chen A., Guo F.-J., Plumbagin induces apoptosis via the p53 pathway and generation of reactive oxygen species in human osteosarcoma cells. Molecular Medicine Reports 2012 5 1 126 132 2-s2.0-84855241139 10.3892/mmr.2011.624
93. Chen M. B., Zhang Y., Wei M. X., Shen W., Wu X. Y., Yao C., Lu P. H., Activation of AMP-activated protein kinase (AMPK) mediates plumbagin-induced apoptosis and growth inhibition in cultured human colon cancer cells. Cell Signal 2013 25 10 1993 2002
94. Lee J. H., Yeon J. H., Kim H., Roh W., Chae J., Park H. O., Kim D. M., The natural anticancer agent plumbagin induces potent cytotoxicity in MCF-7 human breast cancer cells by inhibiting a PI-5 kinase for ROS generation. PLoS One 2012 7 9 e45023
95. Checker R., Sharma D., Sandur S. K., Subrahmanyam G., Krishnan S., Poduval T. B., Sainis K. B., Plumbagin inhibits proliferative and inflammatory responses of T cells independent of ROS generation but by modulating intracellular thiols. Journal of Cellular Biochemistry 2010 110 5 1082 1093 2-s2.0-77954910039 10.1002/jcb.22620
96. Jaquet V., Marcoux J., Forest E., Leidal K. G., McCormick S., Westermaier Y., Perozzo R., Plastre O., Fioraso-Cartier L., Diebold B., Scapozza L., Nauseef W. M., Fieschi F., Krause K.-H., Bedard K., NADPH oxidase (NOX) isoforms are inhibited by celastrol with a dual mode of action. British Journal of Pharmacology 2011 164 2 507 520 2-s2.0-80052235340 10.1111/j.1476-5381.2011. 01439.x